Quarterly Result29 May 2026, 02:17 pm
Natco Pharma: Audited Financial Results for FY26
AI Summary
Natco Pharma Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The results, both standalone and consolidated, were prepared under Indian Accounting Standards (IND-AS) and Regulation 33 of the SEBI Listing Regulations. The Board of Directors approved the results along with an unmodified opinion from the Statutory Auditors. The company also amended its Corporate Social Responsibility Policy and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.
Key Highlights
- Audited financial results (standalone and consolidated) for FY26 approved.
- Results prepared under IND-AS and Regulation 33 of SEBI Listing Regulations.
- Auditor's Report with unmodified opinion enclosed.
- CSR Policy and Code of Practices amended; available on the company website.
- Board meeting commenced at 11.45 a.m. and concluded at 14.05 p.m.
Price Impact
More from NATCOPHARM